Abatacept for Juvenile Idiopathic Arthritis
Links shared publicly online about this topic
Canakinumab Relieves Symptoms In Systemic Juvenile Idiopathic Arthritis
medicalnewstoday.com — “Canakinumab (ACZ885; Novartis) achieves major relief of symptoms in patients with systemic juvenile idiopathic arthritis (SJIA), according to encouraging results from a pivotal phase III trial wit” View full resource at medicalnewstoday.com
Most Recently Shared on September 18, 2011 at 6:05 pm By:
MNT Arthritis News Health News
Canakinumab Relieves Symptoms In Systemic Juvenile Idiopathic Arthritis http://mnt.to/3ZJw #arthritis
High Infection Rates Seen in Juvenile Idiopathic Arthritis
painlive.com — “Children with juvenile idiopathic arthritis have higher rates of hospitalized bacterial infection than children without the condition, and high-dose steroids significantly increase the rate of infection, according to a study published online May 8 in Arthritis & Rheumatism.” View full resource at painlive.com
Most Recently Shared on May 10, 2012 at 3:30 pm By:
High Infection Rates Seen in Juvenile Idiopathic Arthritis http://t.co/GH7f8hYh
Uveitis, Juvenile Idiopathic Arthritis: eMedicine Ophthalmology
emedicine.medscape.com — “Overview: Approximately 6% of all cases of uveitis arise in children. The most frequent cause of chronic intraocular inflammation among children is juvenile idiopathic arthritis (JIA)-associated uveitis. A unifying classification, juvenile idiopathic arthritis (JIA), encompassing juvenile ...” View full resource at emedicine.medscape.com
Most Recently Shared on October 5, 2010 at 12:39 am By:
Ocular immunology & uveitis survey form, created by Dr. C Stephen Foster provides a complete checklist for pt history: http://bit.ly/apeUH1
Pediatrics Medical News about Arthritis, Juvenile Rheumatoid
mdlinx.com — “Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritis” View full resource at mdlinx.com
Most Recently Shared on June 4, 2010 at 6:58 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritis: Arthritis & Rheumatism http://bit.ly/aLNlnw #peds
Rheumatology Medical News about Arthritis, Juvenile Rheumatoid
mdlinx.com — “Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritis” View full resource at mdlinx.com
Most Recently Shared on June 3, 2010 at 8:29 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritis: Arthritis ... http://bit.ly/b0Clut #Rheumatology
Thirty-five percent of children with juvenile idiopathic arthritis
greenmedinfo.com — “This study abstract concerns - Safety and efficacy of influenza vaccination in a prospective longitudinal study of 31 children with juvenile idiopathic arthritis.” View full resource at greenmedinfo.com
Most Recently Shared on April 24, 2012 at 11:04 pm By:
Arthritis Arthritis, Juvenile Rheumatoid on #MDlinx
mdlinx.com — “Arthritis Arthritis, Juvenile Rheumatoid on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on October 5, 2010 at 8:42 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Iron status during anti-TNF therapy in children with juvenile idiopathic arthritis: Clinical Rheumatology http://bit.ly/aNcQuK #Rheumatology
Abatacept Promising for Treatment-Refractory Uveitis in JIA : Internal Medicine News
internalmedicinenews.com — “Internal Medicine News Digital Network is the online destination and multimedia properties of Internal Medicine News, the independent news publication. Our breaking news covers all areas of internal medicine including adolescent medicine; cardiovascular disease; dermatology; diabetes, endocrinology and metabolism; gastroenterology; geriatric medicine; infectious diseases; mental health; oncology and hematology; nephrology and urology; neurology; pulmonary disease and sleep medicine; practice tre” View full resource at internalmedicinenews.com
Most Recently Shared on February 16, 2011 at 5:54 pm By:
Bob Finn - Medical News Net Health News
In juvenile idiopathic arthritis, abatacept promising for refractory uveitis. Bruce Jancin reports. http://bit.ly/ik4p7V
An Introduction to Juvenile Idiopathic Arthritis - Rheumatoid Arthritis
healthcentral.com — “A basic description of Juvenile Idiopathic Arthritis” View full resource at healthcentral.com
Most Recently Shared on June 17, 2011 at 7:59 pm By:
HealthCentral Tips Health Site
@firstaidteam An Intro to Juvenile Idiopathic Arthritis, Symptoms, 3 Main Types http://bit.ly/ki7XBV
Response to Etanercept in Juvenile Idiopathic Arthritis, March 21, 2012, Pang et al. 307 (11): 1140 — JAMA
jama.ama-assn.org — “Response to Etanercept in Juvenile Idiopathic Arthritis, March 21, 2012, Pang et al. 307 (11): 1140 — JAMA” View full resource at jama.ama-assn.org
Most Recently Shared on March 26, 2012 at 10:33 am By:
Response to Etanercept in Juvenile Idiopathic Arthritis, March 21 ... http://t.co/xNFapC4o
Response to Etanercept in Juvenile Idiopathic Arthritis, March 21, 2012, Pang et al. 307 (11): 1140 — JAMA
jama.ama-assn.org — “Response to Etanercept in Juvenile Idiopathic Arthritis, March 21, 2012, Pang et al. 307 (11): 1140 — JAMA” View full resource at jama.ama-assn.org
Most Recently Shared on March 22, 2012 at 1:41 am By:
Response to Etanercept in Juvenile Idiopathic Arthritis [Letters]: (Source: JAMA) http://t.co/D4SCYEHH
Juvenile Idiopathic Arthritis Linked to Elevated Cancer Risk in New Study - ABC News
abcnews.go.com — “Children with juvenile idiopathic arthritis (JIA), the most common form of childhood arthritis, may be at higher risk of developing cancer than children who do not have the condition, according to a new study published in the journal Arthritis & Rheumatism.” View full resource at abcnews.go.com
Most Recently Shared on February 13, 2012 at 11:32 am By:
HealthIT Policy Health News and Health IT
Does Arthritis Raise Kids' Cancer Risk?: Children with juvenile idiopathic arthritis (JIA), the most common form... http://t.co/a70wgmC7
RxEconsult, LLC - Actemra for rheumatoid arthritis and systemic juvenile idiopathic arthritis
rxeconsult.com — “RxEconsult, LLC - Actemra for rheumatoid arthritis and systemic juvenile idiopathic arthritis” View full resource at rxeconsult.com
Most Recently Shared on October 18, 2011 at 3:02 am By:
RxEconsult. If you are in need of healthcare services or information, please visit RxEconsult.
Dr. Ogbru received his Doctorate in Pharmacy from the University of the Pacific School of Pharmacy in 1995. He completed a Pharmacy Practice Residency at the University of Arizona/University Medical Center in 1996. He was a Professor of Pharmacy Practice and a Regional Clerkship Coordinator for the University of the Pacific School of Pharmacy from 1996-99.
Dr. Ogbru has written several journal articles. In 1997, he shared an award from the American Journal of Pain Management for Outstanding Contribution to the Interdisciplinary Pain Management Literature. Over the last 12 years Dr. Ogbru has held several roles in the pharmaceutical industry, including Director of Global Medical Information and Communication." /> Ome Ogbru, PharmD Active Health Library, Doctor, Pharmacist, and PharmD
#Actemra for rheumatoid #arthritis and systemic juvenile idiopathic arthritis http://t.co/zPw6uiBI #Medications #healthcare
Medical News: EULAR: Abatacept Efficacy in Juvenile Arthritis Lasts Beyond Two Years - in Meeting Coverage, EULAR from MedPage Today
medpagetoday.com — “COPENHAGEN -- Children with juvenile idiopathic arthritis continued to respond to abatacept (Orencia) for up to 30 months, researchers said here.” View full resource at medpagetoday.com
Most Recently Shared on June 17, 2009 at 3:44 pm By:
CLINICAL TRIALS• EULAR: Abatacept Efficacy in Juvenile Arthritis Lasts Beyond Two Years (CME/CE) http://tinyurl.com/knbkgg
Rheumatology Medical News about idiopathic arthritis
mdlinx.com — “Predictors of poor response to methotrexate in polyarticular-course juvenile idiopathic arthritis: analysis of the PRINTO methotrexate trial” View full resource at mdlinx.com
Most Recently Shared on June 12, 2010 at 3:01 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Predictors of poor response to methotrexate in polyarticular-course juvenile idiopathic arthritis: an... http://bit.ly/cfQ2Xl #Rheumatology
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
MNT Arthritis News
The latest arthritis / rheumatology news published daily. Articles from research centers, universities and prestigious journals.
-
HCPLive
Your online destination for Pain Management news,events, and resources
-
Medscape Ophtha
Latest medical news, articles, and features from Medscape Ophthalmology.
Advertisement
